Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:38 PM
Ignite Modification Date:
2025-12-24 @ 7:38 PM
NCT ID:
NCT03548103
Eligibility Criteria:
Inclusion Criteria:
* Male or female patients with schizophrenia or mood disorders, followed at Taipei City Psychiatric Center will be the targeted study population. The subjects should fulfill the following criteria:
1. Age between 20 to 65 years.
2. Currently taking antipsychotics or mood stabilizers.
3. BMI should be ≥ 27 kg/m2.
4. Good adherence to medications as recorded by chart.
5. Competent to understand the informed consent and have motivation to decrease their body weight.
Exclusion Criteria:
1. Unstable psychiatric symptoms or physical condition that may interfere the adherence of medication.
2. Medical conditions such as endocrine disease, heart disease, allergy or immunology disease, or impaired liver function (high aminotransferases, alanine, aspartate \>80 IU/L or serum creatinine \>2.5 mg/dl.
3. Pregnant or lactating women.
4. Childbirth within 6 months.
5. Management for weight control within 3 months.
6. Any other conditions deemed unsuitable for trial as evaluated by the physician-in-charge.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
65 Years
Study:
NCT03548103
Study Brief:
Protocol Section:
NCT03548103